Orthocell Limited (ASX:OCC)
1.465
+0.065 (4.64%)
Apr 29, 2025, 11:03 AM AEST
Orthocell Revenue
Orthocell had revenue of 2.41M AUD in the half year ending December 31, 2024, with 183.99% growth. This brings the company's revenue in the last twelve months to 6.31M, up 31.52% year-over-year. In the fiscal year ending June 30, 2024, Orthocell had annual revenue of 5.32M with 25.27% growth.
Revenue (ttm)
6.31M
Revenue Growth
+31.52%
P/S Ratio
53.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
338.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.32M | 1.07M | 25.27% |
Jun 30, 2023 | 4.24M | 2.71M | 177.01% |
Jun 30, 2022 | 1.53M | 513.76K | 50.47% |
Jun 30, 2021 | 1.02M | 298.44K | 41.48% |
Jun 30, 2020 | 719.52K | -226.13K | -23.91% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |
Orthocell News
- 5 months ago - Perth’s billionaire set is piling into this little-known medtech - The Australian Financial Review